Schedule 13G ownership disclosure

Akers Biosciences Inc

Security class unavailable · CUSIP: 00973E102

Event date: 2017-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-17-013588
Form type
SC 13G
Filer
ALPHA CAPITAL ANSTALT
CIK
CIK 1140358
Filed
Dec 22, 2017
Reporting period
Dec 21, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub